Are the results of CONKO-007 changing practice for the management of pancreatic cancer?

Specifically, have the results influenced the management of upfront unresectable patients who are fit and motivated for curative-intent treatment?

CONKO-007

Answer from: Radiation Oncologist at Academic Institution

The results of CONKO-007 are exactly as expected. The clinically relevant endpoint of OS was not improved with the addition of chemotherapy. These results are similar to the PREOPANC-2 trial in BRPC. Since definitions are rarely followed in practice, BRPC and LAPC populations have merged over time; ...

Comments

Radiation Oncologist at Fox Chase Cancer Center
I agree with Dr. @Crane. We have found that with o...

Please select the option that best describes you:

Are the results of CONKO-007 changing practice for the management of pancreatic cancer?

Related Questions